YDL012C Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YDL012C antibody; D2880 antibody; Cysteine-rich and transmembrane domain-containing protein YDL012C antibody
Target Names
YDL012C
Uniprot No.

Target Background

Database Links

KEGG: sce:YDL012C

STRING: 4932.YDL012C

Protein Families
CYSTM1 family
Subcellular Location
Cell membrane; Single-pass membrane protein.

Q&A

What is the YDL012C protein and why is it significant in yeast research?

YDL012C is a member of the cysteine transmembrane (CYSTM) protein superfamily in Saccharomyces cerevisiae. These proteins are characterized by a conserved C-terminal region rich in cysteine residues, initially annotated as a transmembrane domain. Recent research has revealed that YDL012C and related CYSTM proteins are involved in resistance to pathogens and metal detoxification. Bioinformatics analyses clustering YDL012C with YDR210W based on deletion mutant phenotypes suggest its role in stress response mechanisms. Understanding YDL012C function provides insights into fundamental cellular stress response mechanisms conserved across eukaryotes .

How does YDL012C differ structurally and functionally from other CYSTM family proteins in yeast?

While YDL012C belongs to the same CYSTM family as YBR016W (CPP1), YDR210W (CPP2), and YDR034W-B (CPP3), it exhibits distinct characteristics. Unlike the other family members that have been shown to undergo palmitoylation and localize to the plasma membrane, YDL012C has not been demonstrated to be palmitoylated in the same manner. YDL012C contains a unique PPXY motif that enables interaction with the WW domains of the ubiquitin ligase Rsp5, suggesting a potential role in protein degradation pathways not shared by other family members. This functional divergence indicates possible specialized roles in stress response mechanisms despite sharing the conserved cysteine-rich domain characteristic of the CYSTM family .

What epitopes are most suitable for generating YDL012C antibodies?

For generating effective YDL012C antibodies, researchers should focus on unique regions outside the cysteine-rich domain shared by CYSTM family members to avoid cross-reactivity. The N-terminal region of YDL012C contains distinctive sequence elements, including the PPXY motif that interacts with ubiquitin ligases, making it a strong candidate for antibody generation. When designing epitopes, researchers should avoid the cysteine-rich C-terminal domain (previously misannotated as a transmembrane region) since this region shares homology with other CYSTM proteins and could lead to non-specific antibody binding. Synthetic peptides corresponding to amino acids 15-30 of the N-terminal region have proven effective as immunogens for polyclonal antibody production in rabbits .

What are the recommended protocols for validating YDL012C antibody specificity?

A comprehensive validation approach for YDL012C antibodies should include multiple complementary techniques. Begin with Western blot analysis comparing wild-type yeast lysates to YDL012C deletion mutants (ydl012cΔ), looking for absence of the target band in mutant strains. Immunoprecipitation followed by mass spectrometry can confirm antibody specificity by identifying pulled-down proteins. For fluorescence applications, immunofluorescence microscopy comparing antibody staining patterns in wild-type versus deletion strains provides spatial validation. If working with tagged constructs, perform parallel detection using both anti-tag and anti-YDL012C antibodies, confirming signal overlap. Finally, consider preabsorption controls where the antibody is pre-incubated with purified YDL012C protein or immunizing peptide before staining, which should eliminate specific signal. For definitive validation, use CRISPR-engineered epitope modifications to confirm binding site specificity .

What cellular fractionation techniques best preserve YDL012C integrity for antibody detection?

Based on research with related CYSTM family proteins, YDL012C likely presents challenges during cellular fractionation due to potential instability and rapid degradation. To preserve protein integrity, implement a rapid fractionation protocol at 4°C using buffers containing protease inhibitors targeting both vacuolar and proteasomal degradation pathways. Unlike related proteins CPP1-3 that localize to the plasma membrane, YDL012C may have different subcellular distribution, potentially interacting with the ubiquitin ligase Rsp5 .

For effective fractionation, begin with spheroplast preparation using zymolyase, but limit exposure time to prevent degradation. Gently lyse spheroplasts with hypotonic buffer and separate fractions by differential centrifugation: low-speed (1,000×g) for nuclei and cell debris, medium-speed (10,000×g) for mitochondria and large organelles, and high-speed (100,000×g) for microsomes and membrane fractions. Immunoblot each fraction with organelle-specific markers alongside YDL012C antibody to confirm localization. Consider using proteasome inhibitors like MG132 during the procedure, as evidence suggests YDL012C degradation might be proteasome-dependent rather than vacuolar, distinguishing it from typical membrane proteins .

How can researchers effectively study YDL012C post-translational modifications using antibody-based approaches?

Studying YDL012C post-translational modifications requires specialized antibody-based approaches tailored to this unique protein. While related CYSTM family proteins (CPP1-3) undergo palmitoylation, YDL012C's modification profile may differ substantially. To comprehensively map modifications, implement a multi-faceted approach combining immunoprecipitation with mass spectrometry. First, use anti-YDL012C antibodies to pull down the native protein from yeast lysates prepared with deubiquitinase inhibitors to preserve ubiquitination states, particularly important given YDL012C's interaction with the ubiquitin ligase Rsp5 through its PPXY motif .

For ubiquitination analysis, perform tandem immunoprecipitation using anti-YDL012C antibodies followed by anti-ubiquitin detection. To assess potential palmitoylation (though not confirmed for YDL012C), adapt the hydroxylamine treatment protocol used for CPP1-3, which cleaves thioester bonds between cysteines and palmitate groups. Compare mobility shifts before and after treatment to identify potential palmitoylation sites. For phosphorylation studies, use phosphatase treatments followed by phospho-specific antibody detection or Phos-tag SDS-PAGE to resolve phosphorylated species. When designing these experiments, include strains with mutations in candidate modification enzymes (e.g., rsp5 hypomorphic mutants) to establish modification pathways.

What approaches should be used to study the interaction between YDL012C and the ubiquitin ligase Rsp5?

Investigating the YDL012C-Rsp5 interaction requires multiple complementary approaches. Begin with co-immunoprecipitation using anti-YDL012C antibodies in native conditions, followed by immunoblotting for Rsp5. Since Rsp5 is an essential gene, employ temperature-sensitive or hypomorphic alleles instead of deletion strains. Include proteasome inhibitors (MG132) during sample preparation to prevent degradation of ubiquitinated species.

To confirm direct interaction, perform in vitro binding assays using recombinant proteins – particularly the WW domains of Rsp5 and peptides containing the PPXY motif of YDL012C. For in vivo validation, implement proximity ligation assays or fluorescence resonance energy transfer (FRET) using fluorescently tagged proteins. Mutational analysis is crucial – create point mutations in the PPXY motif of YDL012C and observe changes in Rsp5 binding and protein stability.

For functional characterization, assess YDL012C ubiquitination status using ubiquitin mutants (K48R, K63R) to determine ubiquitin chain topology. Compare YDL012C stability in wild-type versus rsp5 mutant backgrounds using cycloheximide chase assays with antibody detection. Finally, perform epistasis analysis with components of endocytic and vacuolar sorting pathways to place YDL012C-Rsp5 interaction in its appropriate cellular context.

How can specialized antibody techniques be applied to understand YDL012C's role in stress response pathways?

To elucidate YDL012C's role in stress response, implement stress-specific antibody applications. Begin by developing phospho-specific antibodies targeting predicted stress-responsive phosphorylation sites on YDL012C, enabling direct monitoring of activation under various stress conditions. Employ chromatin immunoprecipitation (ChIP) with antibodies against stress-responsive transcription factors to determine if YDL012C expression is directly regulated during stress.

Implement proximity-dependent biotin identification (BioID) by fusing a biotin ligase to YDL012C and using streptavidin pull-downs followed by mass spectrometry to identify stress-dependent interaction partners. For temporal dynamics, perform time-course immunofluorescence microscopy using anti-YDL012C antibodies during stress exposure, tracking relocalization patterns.

Create a yeast strain library expressing YDL012C mutants with varying abilities to interact with Rsp5 and other partners, then use antibody-based assays to measure their stress survival capacity. This approach can link specific molecular interactions to stress phenotypes. Complement these studies with quantitative Western blot analysis comparing YDL012C levels across diverse stressors (oxidative, heavy metal, osmotic) to identify condition-specific regulation patterns, further clarifying its place in stress response networks .

How should researchers interpret apparent discrepancies in YDL012C detection between different experimental approaches?

When encountering discrepancies in YDL012C detection across different experimental methods, researchers should consider several protein-specific factors. First, evaluate sample preparation impacts: evidence from related CYSTM proteins indicates that different lysis methods significantly affect protein detection – CPP1 and CPP2 rapidly degrade during zymolyase treatment but remain stable during mechanical disruption with glass beads . Similarly, YDL012C may exhibit preparation-dependent stability.

Second, consider potential rapid degradation via the proteasome. Unlike typical membrane proteins that undergo vacuolar degradation, experiments with related CYSTM proteins show that proteasome inhibitors (MG132) prevent degradation , suggesting a similar mechanism may affect YDL012C detection. Third, assess antibody epitope accessibility issues – if the antibody targets a region involved in protein-protein interactions or post-translational modifications, certain cellular states may mask the epitope.

For accurate interpretation, implement parallel detection methods: fluorescent protein tagging versus antibody staining, multiple antibodies targeting different regions, and native versus denaturing conditions. When analyzing data, normalize YDL012C levels to appropriate loading controls and calculate detection ratios across methods to quantify discrepancies. Finally, validate observations using genetic approaches, such as expressing YDL012C variants with altered Rsp5 interaction capability or stability properties to pinpoint the source of experimental variation.

What are the critical considerations when analyzing YDL012C localization data from immunofluorescence studies?

When analyzing YDL012C localization data from immunofluorescence studies, researchers must address several critical considerations specific to this protein. First, fixation method significantly impacts detection – unlike the plasma membrane-localized CYSTM family members (CPP1-3), YDL012C may have different sensitivity to fixatives due to its unique molecular associations, particularly with the ubiquitin ligase Rsp5 . Compare methanol, formaldehyde, and glutaraldehyde fixation to identify optimal preservation of native localization.

Second, evaluate epitope accessibility challenges by comparing N-terminal versus C-terminal directed antibodies, as YDL012C's interaction with Rsp5 via its PPXY motif may mask specific regions. Third, implement rigorous controls: deletion strains (ydl012cΔ) should show no signal, while peptide competition assays using the immunizing peptide should abolish specific staining.

For accurate interpretation, perform co-localization studies with established markers for cellular compartments using quantitative colocalization coefficients (Pearson's or Mander's). Be aware that YDL012C may rapidly relocalize in response to cellular stresses or during cell cycle progression. When conducting time-course experiments, implement live-cell imaging with GFP-tagged YDL012C alongside fixed-cell immunofluorescence at identical timepoints to distinguish true localization changes from artifacts of sample processing. Finally, validate observations by complementary biochemical fractionation paired with immunoblotting using the same antibody.

How can researchers distinguish between specific and non-specific signals when using YDL012C antibodies in complex experimental systems?

Distinguishing specific from non-specific signals when using YDL012C antibodies requires implementing a comprehensive validation framework tailored to this particular yeast protein. First, genetic controls are essential – all experiments should include parallel analysis of YDL012C deletion strains (ydl012cΔ) to identify background signals, particularly important considering the homology between CYSTM family members that may lead to cross-reactivity .

Second, implement molecular weight verification protocols – YDL012C should appear at its predicted molecular weight, though consider potential shifts due to post-translational modifications, especially given its interaction with the ubiquitin ligase Rsp5. Third, perform epitope competition assays by pre-incubating antibodies with the immunizing peptide, which should eliminate specific signals while leaving non-specific binding intact.

For advanced validation, create a panel of yeast strains expressing YDL012C with systematic mutations in potential epitope regions and observe corresponding changes in antibody recognition patterns. When working with fluorescence applications, quantify signal-to-noise ratios across multiple fields and establish objective thresholds for positive staining. Integrate orthogonal detection methods – where possible, compare antibody-based detection with genetically encoded tags (e.g., GFP-YDL012C) to confirm localization patterns. Finally, validate critical findings using alternative antibody clones targeting different YDL012C epitopes to ensure consistency of observations across detection reagents.

What novel antibody engineering approaches might enhance the study of YDL012C's dynamic behavior during cellular stress responses?

Advanced antibody engineering offers transformative approaches for studying YDL012C's dynamic behavior during stress responses. One promising avenue is developing conformation-specific antibodies that selectively recognize stress-induced structural changes in YDL012C, potentially revealing activation states invisible to conventional antibodies. These could be generated using phage display libraries screened against YDL012C protein prepared under various stress conditions, isolating antibodies that preferentially bind stress-specific conformations.

Another innovative approach is creating fluorescent biosensors by engineering single-chain variable fragments (scFvs) derived from YDL012C antibodies. These can be fused with environmentally sensitive fluorophores that change emission properties upon binding, enabling real-time monitoring of YDL012C conformational changes or interactions during live imaging of stress responses. For multiplexed detection, develop antibody-based proximity sensors where fluorescence or luminescence occurs only when YDL012C interacts with partner proteins, providing spatial and temporal resolution of interaction dynamics during stress.

For single-molecule tracking studies, implement DNA-PAINT (Points Accumulation for Imaging in Nanoscale Topography) using YDL012C antibodies conjugated with DNA docking strands, allowing super-resolution visualization of YDL012C distribution changes during stress. Finally, consider bispecific antibodies that simultaneously target YDL012C and the ubiquitin ligase Rsp5 , enabling direct assessment of their interaction dynamics under various cellular conditions. These advanced tools would provide unprecedented insights into the molecular mechanisms underlying YDL012C's role in cellular stress adaptation.

How can integrative approaches combining antibody-based detection with advanced genomic methods reveal new aspects of YDL012C function?

Integrative approaches combining antibody-based methods with advanced genomic techniques can uncover novel aspects of YDL012C function. One powerful strategy is CUT&Tag (Cleavage Under Targets and Tagmentation), which uses antibodies to guide chromatin tagmentation, revealing genome-wide protein-DNA associations. By applying this with antibodies against transcription factors potentially regulated by stress pathways involving YDL012C, researchers can map global transcriptional changes dependent on YDL012C function during stress responses.

Develop a CRISPR activation/interference (CRISPRa/CRISPRi) library targeting yeast stress response genes, then use anti-YDL012C antibodies for high-throughput immunofluorescence to identify genetic modifiers of YDL012C localization or abundance. This screen would reveal regulatory networks controlling YDL012C function. Similarly, implement antibody-based Perturb-seq, combining CRISPR perturbations with single-cell sequencing, using YDL012C antibodies for protein-level readouts alongside transcriptomic changes.

For functional pathway mapping, implement parallel reporter assays using fluorescent protein fusions to candidate stress response genes, then correlate their expression patterns with YDL012C dynamics detected by antibody staining. This creates a quantitative map of YDL012C-dependent stress response pathways. Finally, apply spatial transcriptomics with antibody-based protein detection to simultaneously visualize YDL012C localization and transcriptional changes in the same cells, revealing spatial relationships between YDL012C activity and its genomic effects. These integrative approaches will provide systems-level understanding of YDL012C's role in coordinating cellular stress responses .

What specialized sample preparation techniques should be employed for optimal YDL012C antibody performance in different applications?

Specialized sample preparation is crucial for optimal YDL012C antibody performance across applications. For immunoblotting, rapid protein extraction is essential to prevent degradation. Unlike related CYSTM proteins that require mechanical disruption with glass beads, YDL012C may be better preserved using direct lysis in hot SDS buffer supplemented with proteasome inhibitors like MG132, which prevents the rapid degradation observed with related proteins . This direct denaturation method bypasses potential degradation during lengthy extraction procedures.

For immunoprecipitation applications, the standard approach using Protein A/G beads may lead to significant loss of YDL012C, particularly if it undergoes rapid ubiquitin-mediated degradation due to its interaction with Rsp5 . Instead, implement crosslinking immunoprecipitation (CLIP) using formaldehyde to stabilize protein complexes before cell lysis, preserving transient interactions. For membrane fractionation, avoid detergents that may disrupt YDL012C associations; instead, use mechanical disruption followed by density gradient ultracentrifugation to separate membrane fractions with intact protein complexes.

For immunofluorescence applications, test mild permeabilization methods that preserve membrane integrity, such as digitonin rather than Triton X-100, to maintain YDL012C in its native context. Always include parallel processing of control samples (deletion strains) to establish background staining levels for each preparation method. Quantitatively compare recovery and detection efficiency across multiple preparation techniques to identify optimal protocols for specific experimental goals.

How can researchers accurately quantify YDL012C expression levels using antibody-based approaches?

Accurate quantification of YDL012C expression requires specialized antibody-based approaches that address this protein's unique characteristics. For immunoblot quantification, implement a standard curve using recombinant YDL012C protein at known concentrations processed alongside experimental samples, allowing absolute quantification. Choose loading controls carefully – traditional housekeeping proteins may not respond similarly to YDL012C under stress conditions that are likely to affect its expression .

For higher precision, implement capillary western immunoassays (Simple Western) which offer superior reproducibility and sensitivity compared to traditional western blotting, particularly valuable for detecting subtle expression changes during stress responses. When analyzing data, use digital image analysis with background subtraction and implement rolling ball algorithms specifically tailored for membrane proteins to enhance signal-to-noise ratio.

Flow cytometry provides single-cell resolution of expression levels, but requires careful optimization of fixation and permeabilization protocols that maintain antibody accessibility while preserving YDL012C native state. For absolute quantification by flow cytometry, use calibration beads with known antibody binding capacity to convert fluorescence intensity to molecules of equivalent soluble fluorochrome (MESF) units.

For spatial analysis of expression, quantitative immunofluorescence microscopy with deconvolution and 3D reconstruction enables subcellular quantification of YDL012C distribution. Implement automated image analysis workflows using machine learning algorithms trained to recognize genuine YDL012C staining patterns versus background. Always validate quantification across multiple methodologies to ensure consistency and reliability of expression measurements.

What are the most effective strategies for generating phospho-specific antibodies for studying YDL012C regulation during stress responses?

Generating effective phospho-specific antibodies for YDL012C requires strategies tailored to this yeast protein's unique properties and stress-responsive phosphorylation sites. Begin with comprehensive in silico analysis using yeast-specific phosphorylation prediction algorithms (e.g., NetPhos Yeast) to identify high-probability phosphorylation sites, focusing on residues within regulatory motifs and regions responding to stress-activated kinases. Prioritize sites conserved across fungal species, suggesting functional importance.

For immunogen design, synthesize phosphopeptides corresponding to the identified sites, ensuring sufficient length (15-20 amino acids) with the phosphorylated residue positioned centrally. Implement the dual-peptide immunization strategy: immunize with the phosphopeptide conjugated to KLH carrier protein, then purify serum using two affinity columns – first positive selection with the phosphopeptide, followed by negative selection against the non-phosphorylated peptide to remove antibodies recognizing the backbone.

Validation requires multiple approaches: phosphatase treatment of yeast lysates should eliminate antibody recognition, while site-directed mutagenesis (serine/threonine to alanine) should similarly abolish signals. For functional validation, assess antibody reactivity in response to specific stressors known to affect YDL012C function, such as chemical compounds identified in phenotypic screens . Consider creating a panel of phospho-specific antibodies against multiple sites to map the phosphorylation dynamics during different stress responses.

To enhance specificity in complex samples, develop proximity ligation assays combining pan-YDL012C antibodies with the phospho-specific antibodies, generating signal only when both epitopes are present in close proximity. This approach significantly reduces background and increases confidence in detecting genuine phosphorylation events on YDL012C during stress responses.

Comparative Analysis of YDL012C and Related CYSTM Family Proteins

ProteinGene NamePalmitoylation StatusCellular LocalizationKey InteractorsKnown Functions
YDL012CYDL012CNot confirmedNot fully characterizedRsp5 (ubiquitin ligase)Potential stress response, contains PPXY motif
CPP1YBR016WPalmitoylated (Erf2/Akr1-dependent)Plasma membrane (polarized)-Stress response, metal detoxification
CPP2YDR210WPalmitoylated (Akr1-dependent)Plasma membrane (partially polarized)-Clustered with YDL012C in phenotypic screens
CPP3YDR034W-BPalmitoylated (Akr1-dependent)Plasma membrane (partially polarized)-Stress response

This table highlights the distinct molecular characteristics of YDL012C compared to other CYSTM family members, particularly regarding its unconfirmed palmitoylation status and unique interaction with the ubiquitin ligase Rsp5 through its PPXY motif, suggesting divergent functions despite shared evolutionary origins .

Experimental Approaches for YDL012C Detection and Functional Analysis

MethodApplicationKey ConsiderationsExpected ResultsPotential Challenges
Western BlottingProtein expression quantificationRapid extraction; proteasome inhibitorsBand at predicted MW; potential ubiquitinated formsRapid degradation; cross-reactivity with other CYSTM proteins
ImmunoprecipitationInteraction studiesMild detergents; crosslinkingPull-down of Rsp5 and other interactorsProtein instability during extraction
ImmunofluorescenceLocalization studiesFixation method optimizationSubcellular distribution patternEpitope masking; background fluorescence
ChIP-seqTranscriptional regulationOptimized crosslinkingBinding sites of TFs regulating YDL012CLow abundance of protein
Phospho-specific detectionSignaling pathway analysisValidation with phosphatase treatmentStress-induced phosphorylation patternsSpecificity of phospho-antibodies

This comprehensive methodological table provides researchers with optimized approaches for studying YDL012C, highlighting critical technical considerations specific to this protein based on current understanding of CYSTM family characteristics and YDL012C's unique properties .

Stress Conditions Affecting YDL012C Expression and Modification

Stress ConditionExpected YDL012C ResponseRecommended Detection MethodControl ExperimentsData Interpretation Guidelines
Heavy Metal ExposurePotential upregulation/relocalizationQuantitative IF and Western blotMetal chelator treatmentCompare to other CYSTM proteins known to function in metal detoxification
Oxidative StressPossible post-translational modificationsPhospho-specific antibodies; mobility shift assaysAntioxidant pre-treatmentAssess temporal dynamics of modifications
Osmotic ShockPotential interaction changesCo-IP with Rsp5 and other partnersIsotonic controlsQuantify interaction strength changes
Heat ShockExpression level changesRT-qPCR with protein-level validationTemperature titrationCompare with known heat shock response genes
Nutrient LimitationDegradation rate changesCycloheximide chase with proteasome inhibitorsReplete media controlsCalculate half-life under different conditions

This table provides a framework for investigating YDL012C's role in diverse stress responses, based on phenotypic data indicating its involvement in resistance to various chemical compounds and stressors. The systematic approach enables researchers to characterize functional responses across multiple experimental conditions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.